NHS England, Biogen reach deal on pricey drug for deadly disorder

World News: . []

NHS England, Biogen reach deal on pricey drug for deadly disorderNHS England said it reached a 'managed access agreement' with Biogen under which it will fund treatment for a limited time and collect data on the drug's effectiveness. NHS England did not disclose the price it will pay for the drug. Biogen confirmed the deal on Tuesday and said it applauded the decision by the National Institute for Health and Care Excellence to recommend funding for Spinraza in the United Kingdom.


Read More: LINK 

Published: .

Search for other references to "england" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us